Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca enters agreement to strengthen cardiovascular pipeline

7th Oct 2024 10:20

(Alliance News) - AstraZeneca PLC on Monday entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd to advance the development of an early stage, novel small molecule lipoprotein disruptor for patients with dyslipidaemia. Read More

TOP NEWS: AstraZeneca hails Airsupra trial results to treat asthma

7th Oct 2024 08:52

(Alliance News) - AstraZeneca PLC on Monday said an independent data monitoring committee recommended an early trial stop for its medication Airsupra due to overwhelming efficacy at pre-planned analysis for the treatment of asthma. Read More

TOP NEWS: AstraZeneca's Calquence gets priority review in US

3rd Oct 2024 11:01

(Alliance News) - AstraZeneca PLC on Thursday said its cancer treatment Calquence obtained priority review by the US Food & Drug Administration for a form of lymphoma. Read More

LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating

3rd Oct 2024 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET MIDDAY: Stocks go red but FTSE 100 up on oil exposure

2nd Oct 2024 12:31

(Alliance News) - Stock prices in London were predominantly lower at midday on Wednesday, though the FTSE 100 continued in the green, thanks to its exposure to the oil and defence sectors. Read More

TOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in US

1st Oct 2024 09:39

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the Food & Drug Administration in the US for some forms of breast cancer. Read More

LONDON MARKET OPEN: FTSE 100 green but other stocks slip ahead of PMIs

1st Oct 2024 09:01

(Alliance News) - Stock prices in London opened a mixed bag in London on Tuesday, with the FTSE 100 in the green, but compatriot indices in the red, ahead of a slew of manufacturing PMIs later in the day. Read More

LONDON BRIEFING: Stocks open in green following UK shop price data

1st Oct 2024 08:05

(Alliance News) - Stocks opened higher in London on Tuesday morning, after data showed that UK shop prices have moved further into deflation. Read More

LONDON MARKET MIDDAY: Stocks stay up as Switzerland cuts rates

26th Sep 2024 12:03

(Alliance News) - Stock prices in London were still in the green at midday on Thursday, during a week in which China has been "the talk of the town". Read More

TOP NEWS: AstraZeneca hails Tagrisso approval in US for cancer form

26th Sep 2024 11:00

(Alliance News) - AstraZeneca PLC on Thursday said that its cancer drug Tagrisso has been approved in the US for certain type of lung cancer. Read More

Pfizer, Moderna and BioNTech take patent fight to Court of Appeal

25th Sep 2024 13:49

(Alliance News) - A multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the UK's Court of Appeal. Read More

TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives

23rd Sep 2024 08:44

(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hopes for the product. Read More

LONDON BRIEFING: REA ups Rightmove bid; AstraZeneca in trial blow

23rd Sep 2024 07:58

(Alliance News) - Stocks in London are to open higher on Monday, ahead of flash composite purchasing managers' index data from the US, the UK and mainland Europe. Read More

AstraZeneca gets FDA approval for FluMist self-administration

20th Sep 2024 19:08

(Alliance News) - AstraZeneca PLC on Friday announced that its influenza vaccine FluMist has been approved for self-administration in the US. Read More

LONDON MARKET MIDDAY: Glum trade for FTSE 100 before Fed decides

18th Sep 2024 12:02

(Alliance News) - Stock prices in London went into Wednesday's afternoon on weaker footing, with trade tepid ahead of the evening's Federal Reserve decision, which is on a knife-edge. Read More

AstraZeneca Fasenra treatment for EGPA approved in the US

18th Sep 2024 09:38

(Alliance News) - AstraZeneca PLC on Wednesday announced Fasenra has been approved in the US to treat adult patients with eosinophilic granulomatosis with polyangiitis, or EGPA. Read More

LONDON BRIEFING: Legal & General sells CALA arm for GBP1.35 billion

18th Sep 2024 07:49

(Alliance News) - The FTSE 100 is called to open lower on Wednesday, as investors digest a UK inflation reading, and look ahead to a US interest rate decision later. Read More

TOP NEWS: AstraZeneca celebrates survival rate of Imfinzi-Imjudo mix

16th Sep 2024 10:05

(Alliance News) - AstraZeneca PLC on Monday said that Imfinzi plus Imjudo showed a clinically meaningful overall survival benefit for patients with a form of liver cancer. Read More

Daiichi, Astra's Enhertu shows clinical activity in brain metastases

13th Sep 2024 17:00

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday reported "substantial clinical activity" for Enhertu in a recent clinical trial. Read More

LONDON MARKET CLOSE: Stocks up as market raises bets on bumper US cut

13th Sep 2024 16:54

(Alliance News) - Shares in London ended the week on the front foot, as markets priced in rising speculation that the Federal Reserve could yet deliver a bigger-than-expected rate cut next week. Read More

FTSE 100 Latest

Value10,585.91

Change61.15